For research use only. Not for therapeutic Use.
Datopotamab deruxtecan (DS-1062, DS-1062A, Anti-TRP2/dxd) is an antibody-drug conjugate (ADC) composed of a humanized anti-TROP2 monoclonal antibody, conjugated to topoisomerase I inhibitor, via a tetrapeptide-based linker. Datopotamab deruxtecan has the potential for use in solid tumors mainly in advanced unresectable advanced NSCLC.
| Catalog Number | I047238 |
| Purity | ≥95% |
| Reference | [1] Okajima D, et al. Mol Cancer Ther. 2021 Dec;20(12):2329-2340. |
